The Growing Pains of Medical Innovation
Biomedical innovations have forever changed human society. Thanks to breakthroughs in basic research and applied clinical science, humanity now enjoys an increased life expectancy, improved quality of life and better...
Toronto, the new Silicon Valley?
While the US wages its trade war against China and further restricts its immigration policies, Canada has been reaping the benefits. By attracting highly skilled workers from around the world,...
The Social & Scientific Intricacies of Effective HIV Prevention
Human Immunodeficiency Virus (HIV) is a retrovirus that primarily infects CD4+ T cells, a population of immune cells that participate in host defense. HIV depletion of CD4+ T cells can...
Issue 2, 2019 – Cover
Advances in medical technologies and therapeutics have had a momentous impact on our society and healthcare systems, allowing individuals suffering from various illnesses to seek vital comfort and rehabilitation. A...
Letter from the Editors – Volume 7, Issue 2
“THERE IS ONLY ONE THING STRONGER THAN ALL THE ARMIES IN THE WORLD, AND THAT IS AN IDEA WHOSE TIME HAS COME.” - VICTOR HUGO In this issue of IMMpress...
Letter from the Chair – Volume 7, Issue 2
[caption id="attachment_4204" align="aligncenter" width="1024"] Dr. Juan Carlos Zúñiga-Pflücker, Chair, Department of Immunology, University of Toronto[/caption] The pace of biomedical innovation continues to accelerate, with Immunological advances leading the way in...
Managing Patents & Commercialization: An Alumni Interview with Dr. Patrycja Thompson
Dr. Patrycja Thompson completed her PhD in 2015 from Dr. Juan Carlos Zúñiga-Pflücker’s laboratory, where she investigated the role of Notch signaling in T cell development and commitment. Now the...
The Business of Antibiotic Resistance: An Unprofitable Venture
By the year 2050, it is predicted that antibiotic microbial resistance (AMR) will kill 10 million people every year. A major driver being the unhindered use of broad-spectrum antibiotics in...
Biomarkers: The Now and The Future
From diagnostic tools to clinical trial enrichment and surrogate endpoint markers, biomarkers are important tools that have the potential to reduce the length, cost, and uncertainty of drug development. A...
Recent Comments